AbstractBenzothiazinones (BTZs) have widely inspired medicinal chemistry and translational research due to their remarkable antitubercular potency and clinical potential. While most structure–activity relationship campaigns have largely focused on lateral chain modifications and substituents on the BTZ core, scaffold hopping strategies have been rarely investigated previously. In this work, we report the first example of ring expansion of the BTZ core toward benzofuran‐ and naphthalene‐fused thiazinones. In vitro testing showed micromolar activity for both compounds, and molecular docking simulations provided insights into their reduced inhibitory capacity toward the enzymatic target (DprE1). Calculated electrochemical potentials revealed a lower susceptibility to reduction as opposed to BTZ drug candidates, in line with the mechanistic requirement for covalent binding.
摘要 苯并噻嗪酮类化合物(BTZs)因其显著的抗结核药效和临床潜力而广泛激发了药物化学和转化研究。虽然大多数结构-活性关系研究主要集中在 BTZ 核心的横向链修饰和取代基上,但以前很少对支架跳跃策略进行研究。在这项工作中,我们首次报告了 BTZ 核心向苯并呋喃和萘融合噻嗪酮扩环的实例。体外测试表明这两种化合物都具有微摩尔活性,而分子对接模拟则揭示了它们对酶靶标(DprE1)的抑制能力降低的原因。计算的电化学电位显示,与 BTZ 候选药物相比,它们的还原敏感性更低,这与共价结合的机理要求一致。